Kenney, Kerry Announce Over $5 Million in NIH Grants to Massachusetts Universities, Hospitals and Health Facilities

Webp adobestock 290960059
Adobe Stock

Kenney, Kerry Announce Over $5 Million in NIH Grants to Massachusetts Universities, Hospitals and Health Facilities

The following press release was published by the Committee on Health, Education, Labor and Pensions on May 12, 2009. It is reproduced in full below.

BOSTON, MA - Senators Edward M. Kennedy and John F. Kerry announced today that nine

health research institutions in Massachusetts will receive seventeen federal grants from the

National Institute of Health totaling over $5 million made under the American Recovery and

Reinvestment Act.

Senator Kennedy said, “These federal funds will enable our outstanding Massachusetts hospitals

and universities to enhance their cutting-edge medical research and develop innovative

treatments and cures of tomorrow."

"These investments will help save lives, secure jobs across our state and ensure Massachusetts

remains a leader in medical technology. I'm pleased that the NIH has provided the resources to

keep us on the cutting edge," said Senator John Kerry.

The recipients of the grants and the purpose and the amount of the grants are as follows:

Beth Israel Deaconess Medical Center

Boston, MA

Studies on the Autocrine control of neutrophil chemotaxis; $383,000

Boston College

Chestnut Hill, MA

Studies on Glucose energy metabolism in the growth and survival of B lymphocytes; $391,250

Boston University

Boston, MA

Engineering Functional Lymphatic Networks in Vitro; $243,750

Brigham and Women’s Hospital

Boston, MA

Studies on Maternal Smoking and the Developing Lung; $88,000

Studies on Red Blood Cell Omega-3 Fatty Acids and Coronary Artery Disease; $243,564

Children’s Hospital Boston

Boston, MA

Studies on the Heterogeneity among human CD4 T lymphocytes; $440,082

Dana Farber Cancer Institute

Boston, MA

Studies on the Potential Therapeutic Target in Lung Cancer; $376,204

Harvard University

Boston, MA

Studies on Drug Targets for Tuberculosis; $406,091

Studies on the Molecular Genetics of HSV DNA Polymerase Gene; $422,084

Studies on the Physical Activity and Survival in Cancer Patients; $88,396

Massachusetts General Hospital

Boston, MA

Studies on Embryonic Vascular Networks and GABA Neuron Migration; $264,875

Studies on the human genetic factors related to susceptibility to the bacteria, which causes

cholera in Bangladesh; $131,760

Studies on multimodal nanoagents for the detection and treatment of atherosclerosis; $265,125

Studies on the neutrophils responses to inflammatory signals; $245,729

Tufts University

Boston, MA

Studies on how the Lyme disease bacterium survives inside ticks; $322,000

Studies on the Hyper-Responsiveness to TLR Agonists in Wild Derived Mice; $412,291

VisualSonics Vevo770 High Resolution In Vivo Imaging System; $342,645

The NIH is the principal Federal agency for supporting medical research, and is responsible for

supporting over 325,000 scientists and researchers in over 3,000 institutions across the country.

For more information on the National Institute of Health’s efforts under the American Recovery

and Reinvestment act, please visit www.nih.gov/recovery.

Source: Committee on Health, Education, Labor and Pensions

More News